Network of Methodology and Management Centres (MMG)

Last updated on 04 July 2025

Main points

  • The Methodology and Management Centres (MMG) are a group of structures providing valuable support to the ANRS MIE in its missions of promoting, coordinating and developing clinical studies.
  • They play a major role in the clinical research platforms piloted by the agency, making a significant contribution to methodological reflection and the structuring of research.

The MMG network: a support system for clinical research

As part of the clinical research it promotes, the ANRS MIE relies on several Methodology and Management Centres (MMG) to ensure the operational coordination of the studies, as well as on a network of hospital departments responsible for the inclusion and follow-up of participants. Clinical platforms such as OPEN-ReMIE, I-REIVAC Emergence and the Strive network are concrete examples of structures supported by the MMG network.

The mission of the MMGs is to support clinical research projects from their conception through to the exploitation of the results. This support includes drafting protocols, discussing study designs and assessing feasibility, thanks to their expertise in methodology, ethics and regulations. Project management continues at a practical and operational level, in coordination with the clinical research associates (CRAs) and data managers, particularly for data management (data protection, database management and cleaning, data analysis and exploitation of results).

Financial support from the ANRS MIE

Some of the agency’s MMGs receive multi-annual cross-funding for some of their staff (CRAs, project managers, quality specialists, statisticians, etc.) under the ‘Clinical Research Networks’ structuring action, which contributes to the organisation of the ANRS MIE clinical research network.

The centres also benefit from common tools (electronic CRF or e-CRF) and support in terms of quality assurance and pharmacovigilance.

MMG mapping

In 2024, the MMG network in mainland France will comprise 9 centres, mainly in the Ile-de-France (5), but also in Bordeaux, Marseille and Rennes.

The annual network meetings enable us to meet the teams behind the MMGs, with whom we collaborate within the network or through various research projects, such as the Strive network in our case. Even if all the information presented at these meetings is not necessarily useful to us, it gives us a direction to follow, to which we can add our own specific features. It also allows us to think about how to deepen our collaborations.

Meetings of the MMG network

The members of the MMG network meet several times a year to discuss their experiences, share their skills and harmonise their practices. These exchanges take place in a variety of complementary formats:

  • An annual face-to-face meeting, organised by the ANRS MIE;
  • ‘Focus Point’ webinars lasting 1.5 hours every two months, organised by the ANRS MIE on topics of interest to the CMGs, such as the DMP (data management plan), open science, the ANRS MIE biobank, RGPD regulation, etc.
  • 2 working groups managed by the ANRS MIE, on datasharing and the e-CRF;
  • 3 internal working groups led by the CMGs:
    • Budget
    • Decarbonisation of research
    • Data matching with the SNDS

The objectives of the MMG network are to harmonise practices, and to strengthen the skills of certain centres by drawing on the expertise of other network members in order to facilitate a rapid response and efficient implementation of studies in the event of an epidemic.

These working groups supported by the MMG network enable us to get to know each other and compare our activities and procedures. Eventually, we will be able to set up joint cross-disciplinary projects, structuring or sharing skills and knowledge. The advantage of having the ANRS MIE as a common promoter will enable stronger actions to be put in place, because they will be carried and supported by the ANRS MIE.

One concrete example is the launch of the ‘Decarbonisation of research’ working group. Its aim is to identify the MMG activities that have the greatest impact on the carbon footprint of clinical trials, in order to find ways of decarbonising the activity. These changes could then be implemented across all CMGs, for example at the request of ANRS MIE as sponsor.

Find out more

Press releases

Launch of the I-REIVAC-Emergence platform

The launch of the I-REIVAC-Emergence platform is a decisive step forward for French clinical research in vaccinology against emerging infectious diseases.

06 May 2025